Intranasal delivery of cell-penetrating anti-NF-κB peptides (Tat-NBD) alleviates infection-sensitized hypoxic-ischemic brain injury

Experimental Neurology

Volumn 247, Issue , 2013, Pages 447-455

  Yang, Dianer ^a   Sun, Yu Yo ^a   Lin, Xiaoyi ^a   Baumann, Jessica M ^a   Dunn, R Scott ^a   Lindquist, Diana M ^a   Kuan, Chia Yi ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Hypoxia ischemia; Microglia; Neuroinflammation; NF kB

Indexed keywords

CELL PENETRATING PEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MINOCYCLINE; TAT NBD PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INFECTION; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; LOW DRUG DOSE; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

HYPOXIA-ISCHEMIA; MICROGLIA; NEUROINFLAMMATION; NF-KB;

ADMINISTRATION, INTRANASAL; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD11B; BRAIN; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROFILAMENT PROTEINS; MUTATION; NF-KAPPA B; PEPTIDES; RATS; TETRAZOLIUM SALTS;

EID: 84881372056     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.01.015     Document Type: Article

References (34)

1. Adhami F., Yu D., Yin W., Schloemer A., Burns K.A., Liao G., Degen J.L., Chen J., Kuan C.Y. Deleterious effects of plasminogen activators in neonatal cerebral hypoxia-ischemia. Am. J. Pathol. 2008, 172:1704-1716.
2. Akpan N., Serrano-Saiz E., Zacharia B.E., Otten M.L., Ducruet A.F., Snipas S.J., Liu W., Velloza J., Cohen G., Sosunov S.A., Frey W.H., Salvesen G.S., Connolly E.S., Troy C.M. Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J. Neurosci. 2011, 31:8894-8904.
3. Alcalá-Barraza S.R., Lee M.S., Hanson L.R., McDonald A.A., Frey W.H., McLoon L.K. Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. J. Drug Target. 2010, 18:179-190.
4. Bednarek N., Svedin P., Garnotel R., Favrais G., Loron G., Schwendiman L., Hagberg H., Morville P., Mallard C., Gressens P. Increased MMP-9 and TIMP-1 in mouse neonatal brain and plasma and in human neonatal plasma after hypoxia-ischemia: a potential marker of neonatal encephalopathy. Pediatr. Res. 2012, 71:63-70.
5. Cady E.B., Iwata O., Bainbridge A., Wyatt J.S., Robertson N.J. Phosphorus magnetic resonance spectroscopy 2h after perinatal cerebral hypoxia-ischemia prognosticates outcome in the newborn piglet. J. Neurochem. 2008, 107:1027-1035.
6. Chen G.Y., Nunez G. Sterile inflammation: sensing and reacting to damage. Nat. Rev. Immunol. 2010, 10:826-837.
7. Choi J., Ifuku M., Noda M., Guilarte T.R. Translocator protein (18kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state. Glia 2011, 59:219-230.
8. Dammann O., Kuban K.C., Leviton A. Perinatal infection, fetal inflammatory response, white matter damage, and cognitive limitations in children born preterm. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:46-50.
9. Dhuria S.V., Hanson L.R., Frey W.H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 2010, 99:1654-1673.
10. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999, 22:391-397.
11. Eklind S., Mallard C., Arvidsson P., Hagberg H. Lipopolysaccharide induces both a primary and a secondary phase of sensitization in the developing rat brain. Pediatr. Res. 2005, 58:112-116.
12. Fan L.W., Pang Y., Lin S., Rhodes P.G., Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 2005, 133:159-168.
13. Khwaja O., Volpe J.J. Pathogenesis of cerebral white matter injury of prematurity. Arch. Dis. Child. Fetal Neonatal Ed. 2008, 93:F153-F161.
14. Kilkenny C., Browne W.J., Cuthill I.C., Emerson M., Altman D.G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010, 8:e1000412.
15. Lawn J.E., Cousens S., Zupan J. 4million neonatal deaths: when? Where? Why?. Lancet 2005, 365:891-900.
16. Lehnardt S., Massillon L., Follett P., Jensen F.E., Ratan R., Rosenberg P.A., Volpe J.J., Vartanian T. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:8514-8519.
17. Leviton A., Allred E.N., Kuban K.C., Hecht J.L., Onderdonk A.B., O'Shea T.M., Paneth N. Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. Pediatr. Res. 2010, 67:95-101.
18. Li Y., Field P.M., Raisman G. Olfactory ensheathing cells and olfactory nerve fibroblasts maintain continuous open channels for regrowth of olfactory nerve fibers. Glia 2005, 52:245-251.
19. Martin A., Boisgard R., Theze B., Van Camp N., Kuhnast B., Damont A., Kassiou M., Dolle F., Tavitian B. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30:230-241.
20. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., Ghosh S. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the Iκ-B kinase complex. Science 2000, 289:1550-1554.
21. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van Bel F., Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008, 39:2129-2137.
22. Nijboer C.H., Heijnen C.J., Groenendaal F., May M.J., van Bel F., Kavelaars A. A dual role of the NF-κB pathway in neonatal hypoxic-ischemic brain damage. Stroke 2008, 39:2578-2586.
23. Pizzi M., Sarnico I., Lanzillotta A., Battistin L., Spano P. Post-ischemic brain damage: NF-κB dimer heterogeneity as a molecular determinant of neuron vulnerability. FEBS J. 2009, 276:27-35.
24. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., Higgins R.D. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
25. Sun Y.Y., Yang D., Kuan C.Y. Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis. J. Neurosci. Methods 2012, 203:122-129.
26. Svedin P., Guan J., Mathai S., Zhang R., Wang X., Gustavsson M., Hagberg H., Mallard C. Delayed peripheral administration of a GPE analogue induces astrogliosis and angiogenesis and reduces inflammation and brain injury following hypoxia-ischemia in the neonatal rat. Dev. Neurosci. 2007, 29:393-402.
27. van den Tweel E.R., Kavelaars A., Lombardi M.S., Groenendaal F., May M., Heijnen C.J., van Bel F. Selective inhibition of nuclear factor-κB activation after hypoxia/ischemia in neonatal rats is not neuroprotective. Pediatr. Res. 2006, 59:232-236.
28. van der Kooij M.A., Nijboer C.H., Ohl F., Groenendaal F., Heijnen C.J., van Bel F., Kavelaars A. NF-kappaB inhibition after neonatal cerebral hypoxia-ischemia improves long-term motor and cognitive outcome in rats. Neurobiol. Dis. 2010, 38:266-272.
29. Vanhamme L., van den Boogaart A., Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior-knowledge. J. Magn. Reson. 1997, 129:35-43.
30. Volpe J.J. Neurology of the Newborn 2008, the Elsevier Inc.
31. Wang X., Stridh L., Li W., Dean J., Elmgren A., Gan L., Eriksson K., Hagberg H., Mallard C. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J. Immunol. 2009, 183:7471-7477.
32. Wintermark P., Boyd T., Gregas M.C., Labrecque M., Hansen A. Placental pathology in asphyxiated newborns meeting the criteria for therapeutic hypothermia. Am. J. Obstet. Gynecol. 2010, 203(579):e571-e579.
33. Yang D., Nemkul N., Shereen A., Jone A., Dunn R.S., Lawrence D.A., Lindquist D., Kuan C.Y. Therapeutic administration of plasminogen activator inhibitor-1 prevents hypoxic-ischemic brain injury in newborns. J. Neurosci. 2009, 29:8669-8674.
34. Yang, D., Sun, Y., Nemkul, N., Baumann, J., Shereen, A., Dunn, R.S., Wills-Karp, M., Lawrence, D., Lindquist, D., Kuan, C., in press. Plasminogen activator inhibitor-1 mitigates brain injury in a rat of infection-sensitized neonatal hypoxia-ischemia. Cereb. Cortex (Epub ahead of print PMID 22556277).